SoliPharma focuses on providing solutions to unmet medical needs in the U.S, China, and other global markets. SoliPharma believes in a mutually beneficial and long-term partnership.
For the U.S. market, SoliPharma constantly looks for distribution partnership for various generic dosage products (ANDA) developed or in development. Our product portfolio covers solid oral, injectable, and inhalation products.
For Chinese market, SoliPharma constantly looks for specialty drug products for in-licensing for the Chinese market. We help our partner assess the market potential, develop market access strategy, navigate the CFDA review and registration process, until together launch the product and maintain the pharmacovigilance.
We also look for global partnership of our patented and patent pending new polymorphs and salt forms.
For more information, please contact: BD@solipharma.com